Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, amid ongoing turmoil over the embattled drugmaker’s delayed financial results and its leader’s health.
Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, amid ongoing turmoil over the embattled drugmaker’s delayed financial results and its leader’s health. Ryan Remiorz AP
Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, amid ongoing turmoil over the embattled drugmaker’s delayed financial results and its leader’s health. Ryan Remiorz AP

Valeant shares slide despite CEO’s return after long illness

February 29, 2016 01:12 PM